Filters

Pp-141 manufacturers

Filters

None products found

pp-141

Tablets

Dossier type
CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Indication: Liver fibrosis/MASH (NASH); solid tumours (in combination with checkpoint inhibitors) Clinical stage: Phase 2 Modality: Small molecule Mechanism / Target: Galectin-3 inhibitor — blocks galectin-3-mediated activation of hepatic stellate cells (fibrosis), TGF-β signalling, and tumour immune exclusion Route / form: Oral tablet (twice daily) Differentiation: First-in-class galectin-3 inhibitor in Phase 2; dual anti-fibrotic and immunomodulatory potential; oral; target well-validated in preclinical models
Manufacturer #39172

Clinical-stage biotechnology company targeting galectin proteins in fibrosis and oncology. Develops first-in-class galectin-3 inhibitors with dual anti-fibrotic and anti-tumour rationale. Wholly owned oral pipeline advancing in liver disease and cancer.
 

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Willing to unlock more features?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.